Three Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference
Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ground floor.
VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology
China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is booming as well as therapeutic areas where he sees promising science.
Improving the Healthcare Financial Experience to Help Care Flow
Zelis CEO Amanda Eisel shares her perspective on how the company is solving the problems of a fragmented health financial system to benefit all.
Health Systems Are Partnering with Reimagine Care to Improve Cancer Treatment
Memorial Hermann Health System and Moffitt Cancer Center have recently struck partnerships with Reimagine Care, a startup focused on providing support to cancer patients via an AI assistant and text messages with oncology experts.
Why Cancer Centers of Excellence May Not Be Right for Every Patient
The notion that patients are always better off receiving treatment at academic centers is flawed, and when an employer offers a COE approach, it can mislead patients to choose that option when care in their local community may be more sensible.
I Used AI Tech To Find My Own Cancer Clinical Trial, and You Can Too
My phone chimed with a notification, signaling the availability of a new CT test result in my online health portal. “Multiple bilateral pulmonary nodules measuring up to 8mm. May represent metastatic disease.” This was several weeks after my very first mammogram–which I underwent shortly after my 40th birthday–detected an anomaly on my left breast. I […]
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources.
Tips for Greater Healthcare Practice Success in 2025
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
Why OneOncology Is Adopting Verily’s Clinical Trial Management System
OneOncology recently announced that it is deploying Verily’s clinical trial management platform across 11 of its community oncology clinics. Adopting Verily’s software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company’s chief medical officer said.
Cancer Moonshot: Would It Even Be Possible in Today’s Fee-For-Service World?
CMS' Enhancing Oncology Model and Cancer Moonshot are the forcing functions to achieve value-based care in oncology. In the spirit of working together to improve lives, this is a MUST for physicians to consider–before they get left behind.
VC Identifies 3 Startups That Will Shake Up the Future of Cancer Care
Oncology Ventures recently announced investments in three cancer startups — VivorCare, Gabbi and Health Universe. The fund's founding partner said each company demonstrated an ability to tackle a specific problem within the cancer care space, such as enabling earlier breast cancer diagnoses and providing personalized care plans for cancer survivors.
What A Nobel Prize-Winner’s Research Means for Cancer Treatment
Drs. Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi's protégé writes why her research is so important.
presented by
What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance
Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.
Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey
Cancer is a serious public health issue, accounting for nearly 10 million deaths and over 19 million new cancer cases around the world in 2020. The WHO estimates that the number of new cancer cases will increase to nearly 29 million in 2040. This alarming statistic is indicative of the huge focus and investment that […]
The cancer death rate is falling — focusing on equity and personalization will help it drop further
Fewer people are dying from cancer due to advances in research, screening and treatment, according to a new report. In order for the death rate to fall further, U.S. oncologists must prioritize personalized treatment and addressing social determinants of health, an expert argued.
Strata, UW Health team up to bring genomic testing to more cancer patients
Strata Oncology partnered with UW Health to integrated its next generation sequencing tumor profiling test into the health system's Epic EHR. Being able to order the test and see its results from within the EHR will help UW clinicians more efficiently leverage genomic findings into their precision oncology treatment plans.
Epic introduces genomic test ordering tool within EHR with Ochsner as first user
Ochsner Health added a tool to its Epic EHR that allows physicians to seamlessly order genomics tests and view results within the EHR. The integration will allow physicians to provide more personalized and effective care now that they can have a single view of their patients’ genomic and clinical data in one place. The news comes two months after MU Health Care added a similar tool into its Oracle Cerner EHR.